Connect with us


Fake Botox Injections Pose Serious Risks, Warns US FDA



US FDA warns of harmful reactions to fake Botox injections, ET HealthWorld

In a recent alert issued by the U.S. Food and Drug Administration, counterfeit versions of AbbVie’s Botox have been distributed to consumers for cosmetic purposes across multiple states. The FDA, along with the U.S. Centers for Disease Control and Prevention (CDC), is currently investigating reports of adverse reactions from individuals who received these counterfeit injections.

As of April 12, a total of 19 individuals from nine different states have reported harmful reactions after receiving counterfeit Botox injections. These injections were administered by unlicensed or untrained individuals in non-healthcare settings such as homes and spas. The affected states include Colorado, Florida, Illinois, Kentucky, Nebraska, New Jersey, New York, Tennessee, and Washington.

The FDA’s investigation is ongoing, and the agency is collaborating with AbbVie, the manufacturer of Botox, to identify and remove suspected counterfeit products within the United States. AbbVie has refrained from commenting on the situation as of now.

Health care professionals and consumers are urged to be cautious and seek authentic sources for cosmetic injections to ensure their safety and well-being. The FDA continues to monitor the situation closely to prevent further harm from these counterfeit products.

For more updates on this developing story, stay tuned to reputable news sources for the latest information.

Click to comment

You must be logged in to post a comment Login

Leave a Reply